Crossmark

The progress and challenges of mesenchymal stromal cell-based therapy for diabetes and its complications

Published Online: 2026-03-16

Authors

Tu, Leyi

Gao, Tianyun

Shen, Pingping

Wang, Bin https://orcid.org/0000-0003-3981-8849
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81571213)

National Natural Science Foundation of China (82070459)
License Information

Text and Data Mining valid from 2026-03-16

Accepted Manuscript valid from 2026-03-16
More Information

Article History

Received: 29 September 2024

Accepted: 2 March 2026

First Online: 16 March 2026

Declarations

:

: Not applicable.

: Not applicable.

: All authors declare that they have no conflicts of interest.

Document is current